393 related articles for article (PubMed ID: 7511757)
1. Disparate inotropic and lusitropic responses to pimobendan in conscious dogs with tachycardia-induced heart failure.
Asanoi H; Ishizaka S; Kameyama T; Ishise H; Sasayama S
J Cardiovasc Pharmacol; 1994 Feb; 23(2):268-74. PubMed ID: 7511757
[TBL] [Abstract][Full Text] [Related]
2. Disparate force-frequency effects of pimobendan and dobutamine in conscious dogs with tachycardia-induced cardiomyopathy.
Joho S; Asanoi H; Ishizaka S; Kameyama T; Inoue H
J Card Fail; 2002 Dec; 8(6):423-30. PubMed ID: 12528096
[TBL] [Abstract][Full Text] [Related]
3. Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure.
Pouleur H; Hanet C; Schröder E; Col J; Van Mechelen H; Etienne J; Rousseau MF
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S18-22. PubMed ID: 2478787
[TBL] [Abstract][Full Text] [Related]
4. The cardiac effects of pimobendan (but not amrinone) are preserved at rest and during exercise in conscious dogs with pacing-induced heart failure.
Ohte N; Cheng CP; Suzuki M; Little WC
J Pharmacol Exp Ther; 1997 Jul; 282(1):23-31. PubMed ID: 9223536
[TBL] [Abstract][Full Text] [Related]
5. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
[TBL] [Abstract][Full Text] [Related]
6. Orally available levosimendan dose-related positive inotropic and lusitropic effect in conscious chronically instrumented normal and heart failure dogs.
Masutani S; Cheng HJ; Hyttilä-Hopponen M; Levijoki J; Heikkilä A; Vuorela A; Little WC; Cheng CP
J Pharmacol Exp Ther; 2008 Apr; 325(1):236-47. PubMed ID: 18174383
[TBL] [Abstract][Full Text] [Related]
7. Lusitropic effects of a Ca2+ sensitization with a new cardiotonic agent, MCI-154, on diseased human hearts.
Mori M; Takeuchi M; Takaoka H; Yokoyama M
Cardiovasc Res; 1995 Dec; 30(6):915-22. PubMed ID: 8746206
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic profile of the cardiotonic agent pimobendan.
van Meel JC; Diederen W
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S1-6. PubMed ID: 2478784
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of a single low oral dose of pimobendan on left ventricular systolic and diastolic function in patients with congestive heart failure.
Ishiki R; Ishihara T; Izawa H; Nagata K; Hirai M; Yokota M
J Cardiovasc Pharmacol; 2000 Jun; 35(6):897-905. PubMed ID: 10836724
[TBL] [Abstract][Full Text] [Related]
10. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
Givertz MM; Andreou C; Conrad CH; Colucci WS
Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544
[TBL] [Abstract][Full Text] [Related]
11. Levosimendan enhances left ventricular systolic and diastolic function in conscious dogs with pacing-induced cardiomyopathy.
Pagel PS; McGough MF; Hettrick DA; Lowe D; Tessmer JP; Jamali IN; Warltier DC
J Cardiovasc Pharmacol; 1997 May; 29(5):563-73. PubMed ID: 9213196
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
[TBL] [Abstract][Full Text] [Related]
13. Mechanoenergetic effect of pimobendan in failing dog hearts.
Goto Y; Hata K
Heart Vessels; 1997; Suppl 12():103-5. PubMed ID: 9476556
[TBL] [Abstract][Full Text] [Related]
14. Effects of atrial natriuretic peptide on left ventricular performance in conscious dogs before and after pacing-induced heart failure.
Ohte N; Cheng CP; Suzuki M; Little WC
J Pharmacol Exp Ther; 1999 Nov; 291(2):589-95. PubMed ID: 10525076
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency.
Pagel PS; Hettrick DA; Warltier DC
Basic Res Cardiol; 1996; 91(4):296-307. PubMed ID: 8874779
[TBL] [Abstract][Full Text] [Related]
16. Altered inotropic and lusitropic responses to heart rate in conscious dogs with tachycardia-induced heart failure.
Asanoi H; Ishizaka S; Joho S; Kameyama T; Inoue H; Sasayama S
J Am Coll Cardiol; 1996 Mar; 27(3):728-35. PubMed ID: 8606289
[TBL] [Abstract][Full Text] [Related]
17. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
Harkin CP; Pagel PS; Tessmer JP; Warltier DC
J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
[TBL] [Abstract][Full Text] [Related]
18. Analysis of isovolumic relaxation in failing hearts by monoexponential time constants overestimates lusitropic change and load dependence: mechanisms and advantages of alternative logistic fit.
Senzaki H; Kass DA
Circ Heart Fail; 2010 Mar; 3(2):268-76. PubMed ID: 20035066
[TBL] [Abstract][Full Text] [Related]
19. Regional alterations of left ventricular contraction and inotropic reserve in conscious dogs with heart failure.
Su JB; Barbe F; Laplace M; Crozatier B; Hittinger L
Cardiovasc Res; 1995 Dec; 30(6):848-56. PubMed ID: 8746198
[TBL] [Abstract][Full Text] [Related]
20. Effects of felodipine on left ventricular systolic and diastolic performance in congestive heart failure.
Cheng CP; Pettersson K; Little WC
J Pharmacol Exp Ther; 1994 Dec; 271(3):1409-17. PubMed ID: 7996453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
